{"id":627,"date":"2024-09-23T08:06:00","date_gmt":"2024-09-23T06:06:00","guid":{"rendered":"https:\/\/www.ipsen.com\/es\/?post_type=press_release&p=627"},"modified":"2024-11-22T10:49:56","modified_gmt":"2024-11-22T08:49:56","slug":"la-comision-europea-aprueba-elafibranor-como-tratamiento-para-la-colangitis-biliar-primaria-cbp","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/spain\/press-releases\/la-comision-europea-aprueba-elafibranor-como-tratamiento-para-la-colangitis-biliar-primaria-cbp\/","title":{"rendered":"La Comisi\u00f3n Europea aprueba elafibranor como tratamiento para la colangitis biliar primaria (CBP)"},"content":{"rendered":"\n